blackboard1965 /
8 August 2016Americas

AbbVie sues Amgen for patent infringement

AbbVie has sued Amgen saying its proposed biosimilar for the Humira (adalimumab) drug infringes 61 patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at